TSH SECRETION--ROLE OF GLUCOCORTICOIDS

TSH 分泌——糖皮质激素的作用

基本信息

  • 批准号:
    2905642
  • 负责人:
  • 金额:
    $ 11.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-08-15 至 2002-06-30
  • 项目状态:
    已结题

项目摘要

Past studies in humans have shown that elevated cortisol levels suppress thyroid stimulating hormone (TSH) secretion, and that TSH secretion is decreased during acute or chronic illnesses. However, the determinants of physiologic (nonstressed) TSH secretion, as well as TSH suppression during stress, are unknown. The overall hypothesis of this proposal is that, in the human, glucocorticoids contain TSH secretion at physiologic levels, and mediate stress-induced TSH suppression at elevated levels. To test this hypothesis, three specific aims will be addressed: 1) The effect of physiologic (nonstressed) levels of glucocorticoids on TSH secretion will be determined. 2) The effect of elevated (stress) levels of glucocorticoids on TSH secretion will be determined. 3) The site of TSH suppression by glucocorticoids at physiologic or stress levels will be clarified. To address these aims, the following experimental tools will be utilized: 1) Measurement of dynamic TSH secretion. TSH is normally secreted in a series of pulses with a circadian variation, and is stimulated by hypothalamic thyrotropin-releasing hormone (TRH). Measurement of pulsatile, circadian, and TRH-stimulated TSH levels is a sensitive way to uncover abnormalities in TSH secretion that are not evident when basal levels are measured. The mathematical technique of deconvolution analysis will be used to obtain precise estimates of basal and pulsatile TSH secretion from measured TSH time series. 2) Administration of mifepristone. Healthy subjects will receive mifepristone, a competitive glucocorticoid antagonist, which will permit a dissociation between stress, endogenous cortisol levels, and TSH secretion. 3) Recruitment of subjects with primary adrenal insufficiency or combined TRH and cortisol deficiency. In these subjects, serum cortisol or TSH levels can be manipulated independently by infusions of hydrocortisone or TRH. These subjects will receive hydrocortisone infusion regimens that reproduce endogenous physiologic or stress patterns of cortisol secretion. Subjects with TRH deficiency will also receive TRH infusions that normalize endogenous TSH levels. This will permit a dissociation between stress, cortisol levels, hypothalamic input to the pituitary gland, and TSH secretion. 4) Fasting model. The stress of illness is difficult to study, since experimental conditions cannot be standardized. To circumvent this problem, short-term fasting has been developed as a model of stress- induced TSH suppression in the human. Insights gained from these studies will advance our understanding of thyroid dysfunction in conditions associated with glucocorticoid elevations. Such results may contribute to continuing efforts to minimize adverse effects of stress and glucocorticoids on human metabolism.
过去对人类的研究表明,皮质醇水平升高会抑制 促甲状腺激素(TSH)分泌,TSH分泌是 在急性或慢性疾病期间减少。 然而, 生理(非应激)TSH分泌,以及TSH抑制, 压力,是未知的。该提案的总体假设是, 人类糖皮质激素含有生理水平的TSH分泌, 并介导应激诱导的高水平TSH抑制。 为了检验这一假设,将讨论三个具体目标: 1)生理(非应激)水平的糖皮质激素对 将测定TSH分泌。 2)糖皮质激素水平升高对TSH的影响 将确定分泌。 3)生理或应激状态下糖皮质激素抑制TSH的部位 水平将得到澄清。 为实现这些目标,将利用以下实验工具: 1)动态TSH分泌的测量。促甲状腺激素通常分泌在 具有昼夜变化的一系列脉冲,并且由 下丘脑促甲状腺激素释放激素(TRH)。 测量 脉动,昼夜节律和TRH刺激的TSH水平是一种敏感的方式, 发现TSH分泌异常,当基础 水平是衡量的。反褶积分析的数学技术 将用于获得基础和脉动TSH的精确估计值 从测量的TSH时间序列分泌。 2)服用米非司酮。 健康受试者将接受 米非司酮是一种竞争性糖皮质激素拮抗剂, 压力、内源性皮质醇水平和TSH之间的分离 分泌物 3)招募原发性肾上腺功能不全或合并 TRH和皮质醇缺乏。在这些受试者中, 水平可以通过注射氢化可的松或 TRH。这些受试者将接受氢化可的松输注方案, 复制皮质醇分泌的内源性生理或应激模式。 TRH缺乏的受试者也将接受TRH输注, 使内源性TSH水平正常化。这将允许分离 压力、皮质醇水平、下丘脑对脑垂体的输入,以及 TSH分泌。 4)禁食模型。疾病的压力很难研究,因为 实验条件不能标准化。为了规避这个 问题,短期禁食已被开发为压力模型- 在人体内引起TSH抑制。 从这些研究中获得的见解将促进我们对 糖皮质激素相关性甲状腺功能障碍 海拔这些结果可能有助于继续努力, 应激和糖皮质激素对人体代谢的不利影响。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: a clinical research center study.
Variable effects of nonsteroidal antiinflammatory agents on thyroid test results.
非甾体类抗炎药对甲状腺检查结果的不同影响。
Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study.
生理皮质醇水平变化对肾上腺功能不全受试者促甲状腺素分泌的影响:一项临床研究中心研究。
Effects of metyrapone administration on thyrotropin secretion in healthy subjects--a clinical research center study.
美替拉酮给药对健康受试者促甲状腺素分泌的影响——一项临床研究中心研究。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY H SAMUELS其他文献

MARY H SAMUELS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY H SAMUELS', 18)}}的其他基金

Neurocognitive and Metabolic Effects of Mild Hypothyroidism
轻度甲状腺功能减退症的神经认知和代谢影响
  • 批准号:
    7991662
  • 财政年份:
    2009
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
轻度甲状腺功能减退症的神经认知和代谢影响
  • 批准号:
    7525500
  • 财政年份:
    2008
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
轻度甲状腺功能减退症的神经认知和代谢影响
  • 批准号:
    8100223
  • 财政年份:
    2008
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
轻度甲状腺功能减退症的神经认知和代谢影响
  • 批准号:
    7670317
  • 财政年份:
    2008
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
轻度甲状腺功能减退症的神经认知和代谢影响
  • 批准号:
    8431427
  • 财政年份:
    2008
  • 资助金额:
    $ 11.26万
  • 项目类别:
NEUROCOGNITIVE EFFECTS OF SUBCLINICAL HYPOTHYROIDISM
亚临床甲状腺功能减退症的神经认知影响
  • 批准号:
    7206561
  • 财政年份:
    2005
  • 资助金额:
    $ 11.26万
  • 项目类别:
NEUROCOGNITIVE EFFECTS OF SUBCLINICAL HYPERTHYROIDISM
亚临床甲状腺功能亢进症的神经认知影响
  • 批准号:
    7206565
  • 财政年份:
    2005
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive effects of subclinical thyroid disease
亚临床甲状腺疾病的神经认知影响
  • 批准号:
    6785875
  • 财政年份:
    2003
  • 资助金额:
    $ 11.26万
  • 项目类别:
Evaluation of Suspected Cushing's Disease or Pseudo-Cushing's Syndrome
疑似库欣病或假性库欣综合征的评估
  • 批准号:
    6981061
  • 财政年份:
    2003
  • 资助金额:
    $ 11.26万
  • 项目类别:
Neurocognitive effects of subclinical hyperthyroidism
亚临床甲状腺功能亢进症的神经认知影响
  • 批准号:
    6981088
  • 财政年份:
    2003
  • 资助金额:
    $ 11.26万
  • 项目类别:

相似海外基金

Electrophysiologic characterization of circadian rhythms of prefrontal cortical network states in a diurnal rodent
昼夜啮齿动物前额皮质网络状态昼夜节律的电生理学特征
  • 批准号:
    10556475
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Examining Sleep, Circadian Rhythms, and Cognitive Functioning in Older Adults at Risk of Dementia
检查有痴呆风险的老年人的睡眠、昼夜节律和认知功能
  • 批准号:
    10606971
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Elucidation of the characteristics of circadian rhythms that contribute to the development of social frailty and investigation of novel intervention therapies.
阐明导致社会脆弱性发展的昼夜节律特征并研究新型干预疗法。
  • 批准号:
    23K12655
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
  • 批准号:
    10663717
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Promoting circadian rhythms to optimize gut-to-brain signaling for Alzheimer's disease
促进昼夜节律,优化阿尔茨海默病的肠道到大脑信号传导
  • 批准号:
    10717948
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Research on the entrainment factors of circadian rhythms contributing to the relief of premenstrual syndrome sufferingss
缓解经前综合症痛苦的昼夜节律影响因素研究
  • 批准号:
    23H03208
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment
治疗阿片类药物使用障碍的药物差异调节本质光敏性视网膜神经节细胞功能、睡眠和昼夜节律:对治疗的影响
  • 批准号:
    10783274
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Fundamental Mechanisms of Higher-Order Circadian Rhythms
高阶昼夜节律的基本机制
  • 批准号:
    10713148
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Determining the role of circadian rhythms in Chlamydia associated tubal infertility
确定昼夜节律在衣原体相关输卵管不孕症中的作用
  • 批准号:
    10629735
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
Feasibility of a mobile application for sleep and circadian rhythms in pediatric patients with acute lymphoblastic leukemia and their caregivers
急性淋巴细胞白血病儿科患者及其护理人员睡眠和昼夜节律移动应用程序的可行性
  • 批准号:
    10603223
  • 财政年份:
    2023
  • 资助金额:
    $ 11.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了